• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维化的新治疗方法:利用翻译调控

New therapeutic approaches for fibrosis: harnessing translational regulation.

作者信息

Gill Sumeen Kaur, Gomer Richard H

机构信息

Department of Biology, Texas A&M University, College Station, TX, USA.

Department of Biology, Texas A&M University, College Station, TX, USA.

出版信息

Trends Mol Med. 2025 Jul;31(7):640-651. doi: 10.1016/j.molmed.2024.11.012. Epub 2024 Dec 16.

DOI:10.1016/j.molmed.2024.11.012
PMID:39690057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12341003/
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating lung disease characterized by excessive extracellular matrix deposition and tissue scarring. The median survival of patients with IPF is only 4.5 years following diagnosis, and effective treatment options are scarce. Recent studies found aberrant translation of specific mRNAs in various fibrosing diseases, highlighting the role of key translational regulators, including RNA binding proteins (RBPs), microRNAs, long noncoding RNAs, and transcript modifications. Notably, when inhibited, 10 profibrotic RBPs cause a significant attenuation of fibrosis, illuminating potential therapeutic targets. In this review, we describe translational regulation in fibrosis and highlight a model where a conserved evolutionary mechanism may explain this regulation.

摘要

特发性肺纤维化(IPF)是一种进行性且使人衰弱的肺部疾病,其特征为细胞外基质过度沉积和组织瘢痕形成。IPF患者确诊后的中位生存期仅为4.5年,且有效的治疗选择匮乏。最近的研究发现,特定mRNA在各种纤维化疾病中存在异常翻译,这凸显了关键翻译调节因子的作用,包括RNA结合蛋白(RBP)、微小RNA、长链非编码RNA和转录修饰。值得注意的是,当受到抑制时,10种促纤维化RBP会使纤维化显著减轻,这为潜在的治疗靶点提供了线索。在本综述中,我们描述了纤维化中的翻译调控,并强调了一种保守的进化机制可能解释这种调控的模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/081d171246fc/nihms-2099994-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/bcbbb1c9d9d1/nihms-2099994-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/0193366c6f63/nihms-2099994-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/83a2205e8389/nihms-2099994-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/081d171246fc/nihms-2099994-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/bcbbb1c9d9d1/nihms-2099994-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/0193366c6f63/nihms-2099994-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/83a2205e8389/nihms-2099994-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/12341003/081d171246fc/nihms-2099994-f0004.jpg

相似文献

1
New therapeutic approaches for fibrosis: harnessing translational regulation.纤维化的新治疗方法:利用翻译调控
Trends Mol Med. 2025 Jul;31(7):640-651. doi: 10.1016/j.molmed.2024.11.012. Epub 2024 Dec 16.
2
Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications.肺纤维化中的翻译调控因子:微小RNA、长链非编码RNA和转录修饰
Cells. 2025 Apr 3;14(7):536. doi: 10.3390/cells14070536.
3
Construction and Bioinformatics Analysis of ceRNA Regulatory Networks in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中ceRNA调控网络的构建及生物信息学分析
Biochem Genet. 2024 Jun 13. doi: 10.1007/s10528-024-10853-y.
4
A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis.系统性硬化症和特发性肺纤维化中重叠微小RNA模式的系统评价
Eur Respir Rev. 2017 May 17;26(144). doi: 10.1183/16000617.0125-2016. Print 2017 Jun 30.
5
Pulmonary fibrosis and exosomes: pathways to treatment.肺纤维化与外泌体:治疗途径
Mol Biol Rep. 2025 Jul 23;52(1):749. doi: 10.1007/s11033-025-10855-y.
6
PAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis.肺纤维化需要纤溶酶原激活物抑制剂-1(PAI-1)与sortilin相关受体1相互作用。
JCI Insight. 2025 Apr 29;10(11). doi: 10.1172/jci.insight.186131. eCollection 2025 Jun 9.
7
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis.琥珀酸通过琥珀酸/琥珀酸受体1轴加重肺纤维化。
Am J Physiol Lung Cell Mol Physiol. 2025 May 1;328(5):L671-L684. doi: 10.1152/ajplung.00286.2024. Epub 2025 Mar 27.
8
The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype.衰老的细胞外基质与衰老相关分泌表型的促纤维化作用。
Am J Physiol Cell Physiol. 2023 Sep 1;325(3):C565-C579. doi: 10.1152/ajpcell.00124.2023. Epub 2023 Jul 24.
9
Disulfiram activation of prostaglandin E2 synthesis: a novel antifibrotic mechanism in pulmonary fibrosis.双硫仑激活前列腺素E2合成:肺纤维化中的一种新型抗纤维化机制。
J Pharmacol Exp Ther. 2025 Jun;392(6):103588. doi: 10.1016/j.jpet.2025.103588. Epub 2025 Apr 21.
10
LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-β signalling.LMO7通过转化生长因子-β信号通路驱动小鼠体内促纤维化成纤维细胞极化和肺纤维化。
Acta Pharmacol Sin. 2025 Feb 25. doi: 10.1038/s41401-025-01488-9.

引用本文的文献

1
Translational Regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript Modifications.肺纤维化中的翻译调控因子:微小RNA、长链非编码RNA和转录修饰
Cells. 2025 Apr 3;14(7):536. doi: 10.3390/cells14070536.

本文引用的文献

1
CircSlc17a5 controlled by VLDLR/QKI pathway regulated the choroidal angiogenesis.VLDLR/QKI 通路调控的 CircSlc17a5 调节脉络膜血管生成。
Biochim Biophys Acta Mol Cell Res. 2024 Oct;1871(7):119802. doi: 10.1016/j.bbamcr.2024.119802. Epub 2024 Jul 26.
2
RNA modifications in pulmonary diseases.肺部疾病中的RNA修饰
MedComm (2020). 2024 May 3;5(5):e546. doi: 10.1002/mco2.546. eCollection 2024 May.
3
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.
靶向转化生长因子-β异构体用于癌症治疗干预的进展与挑战:基于机制的视角
Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533.
4
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view.细胞因子和分子通路在SARS-CoV-2感染后肺纤维化中的作用:生理病理学(再)综述
Biomedicines. 2024 Mar 13;12(3):639. doi: 10.3390/biomedicines12030639.
5
Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways.靶向 GPR65 通过抑制 JNK 和 NF-κB 通路缓解肝炎症和肝纤维化。
Mil Med Res. 2023 Nov 25;10(1):56. doi: 10.1186/s40779-023-00494-4.
6
The impact of fibrotic diseases on global mortality from 1990 to 2019.1990年至2019年纤维化疾病对全球死亡率的影响。
J Transl Med. 2023 Nov 16;21(1):818. doi: 10.1186/s12967-023-04690-7.
7
Epigenetic signatures in cardiac fibrosis: Focusing on noncoding RNA regulators as the gatekeepers of cardiac fibroblast identity.心脏纤维化中的表观遗传学特征:聚焦于非编码 RNA 调节剂作为心脏成纤维细胞身份的守门员。
Int J Biol Macromol. 2024 Jan;254(Pt 1):127593. doi: 10.1016/j.ijbiomac.2023.127593. Epub 2023 Oct 26.
8
The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease.微小RNA在导致慢性肾脏病的肾纤维化中的作用
Biomedicines. 2023 Aug 23;11(9):2358. doi: 10.3390/biomedicines11092358.
9
On the Decoupling of Evolutionary Changes in mRNA and Protein Levels.mRNA 和蛋白质水平进化变化的解耦。
Mol Biol Evol. 2023 Aug 3;40(8). doi: 10.1093/molbev/msad169.
10
Cooperativity boosts affinity and specificity of proteins with multiple RNA-binding domains.协同作用增强了具有多个RNA结合结构域的蛋白质的亲和力和特异性。
NAR Genom Bioinform. 2023 Jun 9;5(2):lqad057. doi: 10.1093/nargab/lqad057. eCollection 2023 Jun.